EG16175A - Process for preparing of immonoglobulin conjugates - Google Patents
Process for preparing of immonoglobulin conjugatesInfo
- Publication number
- EG16175A EG16175A EG202/84A EG20284A EG16175A EG 16175 A EG16175 A EG 16175A EG 202/84 A EG202/84 A EG 202/84A EG 20284 A EG20284 A EG 20284A EG 16175 A EG16175 A EG 16175A
- Authority
- EG
- Egypt
- Prior art keywords
- conjugates
- immonoglobulin
- preparing
- sub
- immunoglobulin
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000863480 Vinca Species 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8308857 | 1983-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG16175A true EG16175A (en) | 1986-12-30 |
Family
ID=10540516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG202/84A EG16175A (en) | 1983-03-30 | 1984-03-28 | Process for preparing of immonoglobulin conjugates |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4845200A (OSRAM) |
| EP (1) | EP0121388B1 (OSRAM) |
| JP (1) | JPS59190924A (OSRAM) |
| KR (1) | KR890002634B1 (OSRAM) |
| AT (1) | ATE53496T1 (OSRAM) |
| AU (1) | AU570963B2 (OSRAM) |
| BG (1) | BG42837A3 (OSRAM) |
| CA (1) | CA1210696A (OSRAM) |
| DE (1) | DE3482444D1 (OSRAM) |
| DK (1) | DK167884A (OSRAM) |
| EG (1) | EG16175A (OSRAM) |
| ES (1) | ES531081A0 (OSRAM) |
| FI (1) | FI80383C (OSRAM) |
| GB (1) | GB2137210B (OSRAM) |
| GR (1) | GR79899B (OSRAM) |
| HU (1) | HU191647B (OSRAM) |
| IE (1) | IE57218B1 (OSRAM) |
| IL (1) | IL71366A (OSRAM) |
| NZ (1) | NZ207675A (OSRAM) |
| PH (1) | PH23222A (OSRAM) |
| PL (1) | PL144887B1 (OSRAM) |
| PT (1) | PT78322B (OSRAM) |
| SU (1) | SU1362404A3 (OSRAM) |
| ZA (1) | ZA842347B (OSRAM) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86157A1 (fr) * | 1985-11-12 | 1987-06-26 | Omnichem Sa | Nouveau procede de fabrication de conjugues de la vinblastine et de ses derives |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| FI860456A7 (fi) * | 1985-07-16 | 1987-01-17 | Huhtamaeki Oy Laeaeketehdas Le | Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning. |
| CA1289880C (en) * | 1985-12-06 | 1991-10-01 | Jeffrey L. Winkelhake | Anti-human ovarian cancer immunotoxins and methods of use thereof |
| CA1287578C (en) * | 1985-12-06 | 1991-08-13 | Michael J. Bjorn | Anti-human ovarian cancer immunotoxins and methods of use thereof |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| ZA873600B (en) * | 1986-05-27 | 1988-12-28 | Lilly Co Eli | Immunoglobulin conjugates |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| US4994558A (en) * | 1986-12-24 | 1991-02-19 | Eli Lilly And Company | Immunoglobulin conjugates |
| US4814438A (en) * | 1986-12-24 | 1989-03-21 | Eli Lilly And Company | Immunoglobulin conjugates of 2',2'-difluronucleosides |
| RU1787160C (ru) * | 1986-12-24 | 1993-01-07 | Эли Лилли Энд Компани | Способ получени иммуноглобулинового конъюгата |
| IL89043A0 (en) * | 1988-01-27 | 1989-08-15 | Lilly Co Eli | Antibody conjugates |
| FR2626882B1 (fr) * | 1988-02-08 | 1991-11-08 | Ire Celltarg Sa | Conjugues de derives de vinca comportant une chaine detergente en position c-3 |
| IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
| US5006652A (en) * | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5094849A (en) * | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5028697A (en) * | 1988-08-08 | 1991-07-02 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
| US5010176A (en) * | 1988-11-10 | 1991-04-23 | Eli Lilly And Company | Antibody-drug conjugates |
| DE4122210C2 (de) * | 1991-07-04 | 1999-04-01 | Deutsches Krebsforsch | Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung |
| US5879656A (en) * | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| US7097839B1 (en) | 1993-10-26 | 2006-08-29 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| CN110790777B (zh) * | 2019-10-24 | 2021-05-25 | 广州白云山汉方现代药业有限公司 | 一种长春新碱类化合物杂质及其制备方法与应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4045420A (en) * | 1973-05-29 | 1977-08-30 | Syva Company | Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof |
| US4026879A (en) * | 1976-03-23 | 1977-05-31 | Hoffmann-La Roche Inc. | Antigen-containing propranolol derivatives |
| US4069105A (en) * | 1977-03-03 | 1978-01-17 | Syva Company | Lidocaine antigens and antibodies |
| US4243654A (en) * | 1978-09-11 | 1981-01-06 | Syva Company | Oxazepam derivatives for immunoassay reagents |
| US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
| US4223013A (en) * | 1978-12-29 | 1980-09-16 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
| FI820020A7 (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobuliinikonjugaatteja. |
| FR2516794B1 (fr) * | 1981-11-20 | 1985-10-25 | Sanofi Sa | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique |
| JPS59116229A (ja) * | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
| ATE57187T1 (de) * | 1983-03-30 | 1990-10-15 | Lilly Industries Ltd | Vincaleukoblastin-derivate. |
-
1984
- 1984-03-26 DK DK167884A patent/DK167884A/da not_active IP Right Cessation
- 1984-03-26 AT AT84302004T patent/ATE53496T1/de not_active IP Right Cessation
- 1984-03-26 DE DE8484302004T patent/DE3482444D1/de not_active Expired - Fee Related
- 1984-03-26 EP EP84302004A patent/EP0121388B1/en not_active Expired - Lifetime
- 1984-03-26 GR GR74217A patent/GR79899B/el unknown
- 1984-03-26 GB GB08407766A patent/GB2137210B/en not_active Expired
- 1984-03-27 IL IL71366A patent/IL71366A/xx unknown
- 1984-03-27 PT PT78322A patent/PT78322B/pt not_active IP Right Cessation
- 1984-03-27 CA CA000450616A patent/CA1210696A/en not_active Expired
- 1984-03-27 AU AU26143/84A patent/AU570963B2/en not_active Ceased
- 1984-03-28 PH PH30460A patent/PH23222A/en unknown
- 1984-03-28 EG EG202/84A patent/EG16175A/xx active
- 1984-03-28 NZ NZ207675A patent/NZ207675A/en unknown
- 1984-03-29 HU HU841259A patent/HU191647B/hu not_active IP Right Cessation
- 1984-03-29 IE IE772/84A patent/IE57218B1/xx unknown
- 1984-03-29 PL PL1984246931A patent/PL144887B1/pl unknown
- 1984-03-29 SU SU843721031A patent/SU1362404A3/ru active
- 1984-03-29 FI FI841260A patent/FI80383C/fi not_active IP Right Cessation
- 1984-03-29 ES ES531081A patent/ES531081A0/es active Granted
- 1984-03-29 ZA ZA842347A patent/ZA842347B/xx unknown
- 1984-03-29 BG BG064893A patent/BG42837A3/xx unknown
- 1984-03-30 KR KR1019840001690A patent/KR890002634B1/ko not_active Expired
- 1984-03-30 JP JP59063140A patent/JPS59190924A/ja active Pending
-
1986
- 1986-06-23 US US06/877,598 patent/US4845200A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG16175A (en) | Process for preparing of immonoglobulin conjugates | |
| DE3369887D1 (en) | Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives | |
| NO179483C (no) | Fremgangsmåte for å opprette diffusjonsbinding mellom korrosjonsbestandige materialer | |
| ZA831833B (en) | New conjugates associating,by covalent bond,an enzyme with an antibody,and medicinal associations using the said conjugates | |
| EP0307480A4 (en) | PROCESS FOR THE PREPARATION OF AN ANTIBODY COMPLEX. | |
| HUT46916A (en) | Process for producing spiro-bonded pyrrolidin-2,5-dione derivatives | |
| BG40318A3 (bg) | Метод за получаване на имуноглобулинови производни на виндезина | |
| BG42004A3 (en) | Method for preparing pyridyl compounds | |
| HUT39428A (en) | Process for producing 1-substituted, condensed indolo-3-carboxamide derivatives | |
| AU2527284A (en) | Urea linked immunogens, antibodies and preparative method | |
| EP0194158A3 (en) | Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays | |
| SE8800886D0 (sv) | Immunoglobulin conjugates | |
| FI854624A7 (fi) | Syaanivedyn reaktiotuotteiden valmistusmenetelmä. | |
| PH21133A (en) | Process for preparing glycosidic linkage related antigen | |
| FI853560A7 (fi) | Menetelmä pregnaani-johdannaisten valmistamiseksi. | |
| GB2158434B (en) | Process for preparing2,2-bishalomethylpenam derivatives | |
| DE3569731D1 (en) | Process for the preparation of optionally substituted benz(c,d)-indol-2-ones (naphtholactames) | |
| HU9203770D0 (en) | Method for producing stable immunogenic suspenision, one for improving binding ability of antibody as well as diagnostic tool set | |
| BG37524A3 (en) | Method for preparing 1, 5- benzothiazepines derivatives | |
| EP0334958A4 (en) | MONOCLONAL ANTIBODIES. |